Literature DB >> 11845938

Results of a cooperative educational program to improve prostate pathology reports among patients undergoing radical prostatectomy.

Pascal James Imperato1, Jerry Waisman, Marcia Wallen, Veronica Pryor, Mary Rojas, Kathleen Giardelli, Maryanne Daley.   

Abstract

The information contained in pathology reports of radical prostatectomy specimens is critically important to treating physicians for the selection of adjuvant therapy, the evaluation of therapy, estimating prognosis, and analyzing outcomes. This information is also important to patients and their families. The first phase of this study consisted of a retrospective chart review of 554 cases of radical prostatectomy (ICD-9-CM procedure code of 60.5) in New York State for the second six-month period of 1996. This review focused on ten elements (quality indicators): submission of a frozen section, location of the adenocarcinoma, proportion of specimen involved by adenocarcinoma, perineural involvement, vascular involvement, seminal vesicle status, periprostate fat status, number of nodes submitted, status of nodes, and PIN (prostate intra-epithelial neoplasia). The second phase of this project consisted of an educational feedback program involving the directors of pathology laboratories in all hospitals in New York State. A post-intervention review of the medical charts of all male Medicare patients discharged from New York State acute care hospitals with the ICD-9-CM procedure code of 60.5 (radical prostatectomy) was conducted for the six-month period February 1 through July 31, 1999. A total of 304 charts were reviewed. Performance on the ten indicators in the first phase of the study varied from 14.8% (periprostate fat status) to 85.9% (seminal vesicle involvement). Performance for all hospitals was 50% for four quality indicators and less than 70% for seven. Post-intervention improvements in performance occurred with nine of the ten quality indicators. These improvements ranged from 1.4% (status of lymph nodes submitted) to 23.9% (proportion of specimen involved by adenocarcinoma). The results of this study demonstrate that the issues identified in the baseline with radical prostatectomy pathology reports were amenable to a cooperative educational intervention.

Entities:  

Mesh:

Year:  2002        PMID: 11845938     DOI: 10.1023/a:1013823409165

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  8 in total

1.  The use of quality indicators for assessing radical prostatectomy specimens.

Authors:  P J Imperato; J Waisman; M Wallen; V Pryor; H Starr; M Rojas; K Terry; K Giardelli
Journal:  Am J Med Qual       Date:  2000 Sep-Oct       Impact factor: 1.852

2.  Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: a basis for checklists. Cancer Committee.

Authors:  J R Srigley; M B Amin; D G Bostwick; D J Grignon; M E Hammond
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

Review 3.  Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.

Authors:  D G Bostwick; D J Grignon; M E Hammond; M B Amin; M Cohen; D Crawford; M Gospadarowicz; R S Kaplan; D S Miller; R Montironi; T F Pajak; A Pollack; J R Srigley; J W Yarbro
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

4.  Recommendations for the reporting of resected prostate carcinomas. Association of Directors of Anatomic and Surgical Pathology.

Authors:  M B Amin; D Grignon; D Bostwick; V Reuter; P Troncoso; A G Ayala
Journal:  Am J Clin Pathol       Date:  1996-06       Impact factor: 2.493

5.  Trends in radical prostatectomy in New York State.

Authors:  P J Imperato; R P Nenner; T O Will
Journal:  Am J Med Qual       Date:  1996       Impact factor: 1.852

6.  Radical prostatectomy specimens among Medicare patients in New York State: a review of pathologists' reports.

Authors:  P J Imperato; J Waisman; R P Nenner
Journal:  Arch Pathol Lab Med       Date:  1998-11       Impact factor: 5.534

7.  Radical prostatectomy: lower rates among African-American men.

Authors:  P J Imperato; R P Nenner; T O Will
Journal:  J Natl Med Assoc       Date:  1996-09       Impact factor: 1.798

8.  Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland. A publication of the cancer committee, college of american pathologists. Task Force on the Examination of Specimens Removed From Patients With Prostate Cancer.

Authors:  D E Henson; R V Hutter; G Farrow
Journal:  Arch Pathol Lab Med       Date:  1994-08       Impact factor: 5.534

  8 in total
  4 in total

Review 1.  Understanding variation in the quality of the surgical treatment of prostate cancer.

Authors:  Florian R Schroeck; Bruce L Jacobs; Brent K Hollenbeck
Journal:  Am Soc Clin Oncol Educ Book       Date:  2013

2.  Florida Initiative for Quality Cancer Care: improvements in breast cancer quality indicators during a 3-year interval.

Authors:  Christine Laronga; Jhanelle E Gray; Erin M Siegel; Ji-Hyun Lee; William J Fulp; Michelle Fletcher; Fred Schreiber; Richard Brown; Richard Levine; Thomas Cartwright; Guillermo Abesada-Terk; George Kim; Carlos Alemany; Douglas Faig; Phillip Sharp; Merry-Jennifer Markham; David Shibata; Mokenge Malafa; Paul B Jacobsen
Journal:  J Am Coll Surg       Date:  2014-07-01       Impact factor: 6.113

3.  Evaluating the quality of colorectal cancer care in the state of Florida: results from the Florida Initiative for Quality Cancer Care.

Authors:  Erin M Siegel; Paul B Jacobsen; Mokenge Malafa; William Fulp; Michelle Fletcher; Ji-Hyun Lee; Jesusa Corazon R Smith; Richard Brown; Richard Levine; Thomas Cartwright; Guillermo Abesada-Terk; George Kim; Carlos Alemany; Douglas Faig; Philip Sharp; Merry-Jennifer Markham; David Shibata
Journal:  J Oncol Pract       Date:  2012-06-12       Impact factor: 3.840

4.  Florida Initiative for Quality Cancer Care: improvements on colorectal cancer quality of care indicators during a 3-year interval.

Authors:  Erin M Siegel; Paul B Jacobsen; Ji-Hyun Lee; Mokenge Malafa; William Fulp; Michelle Fletcher; Jesusa Corazon R Smith; Richard Brown; Richard Levine; Thomas Cartwright; Guillermo Abesada-Terk; George Kim; Carlos Alemany; Douglas Faig; Philip Sharp; Merry-Jennifer Markham; David Shibata
Journal:  J Am Coll Surg       Date:  2013-11-23       Impact factor: 6.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.